Publications in VIVO

Co-author Network

Burgos, Marcos Professor

Dr. Marcos Burgos is an Associate Professor and Medical Director of the Tuberculosis Program for the New Mexico Department of Health. Dr. Burgos received his MD from UCSD and completed his internship and residency in internal medicine at Yale University. He completed his fellowship in Infectious Diseases at Stanford University and a tuberculosis fellowship at UCSF. He is board certified in Internal Medicine and Infectious Diseases. Dr. Burgos’ His research interests include evolution of M. tuberculosis, molecular epidemiology, clinical trials of tuberculosis and tuberculosis control. In his role as Medical Director of the tuberculosis program, he supervises the care of patients and consults with medical providers to oversee treatment of tuberculosis in New Mexico. Dr. Burgos is also collaborating with the International Union Against Tuberculosis and Lung Disease (The Union), where he is currently a member of the steering committee on clinical trials and coordinator of clinical trials in Latin America for tuberculosis. He currently has collaborative research projects in clinical trials with The Union in Bolivia, Colombia and Peru.

Publications
Contact
View All

selected publications

academic article
- Multidrug-resistant tuberculosis treatment failure detection depends on monitoring interval and microbiological method.. The European respiratory journal. 48:1160-1170. 2016
- A randomised Phase II trial to evaluate the toxicity of high-dose rifampicin to treat pulmonary tuberculosis.. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 20:832-838. 2016
- Virulence of Mycobacterium tuberculosis after Acquisition of Isoniazid Resistance: Individual Nature of katG Mutants and the Possible Role of AhpC. 2016
- First insights into circulating Mycobacterium tuberculosis complex lineages and drug resistance in Guinea.. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases. 33:314-319. 2015
- Results at 30 months of a randomised trial of FDCs and separate drugs for the treatment of tuberculosis.. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 18:1252-1254. 2014
- Social and clinical predictors of drug-resistant tuberculosis in a public hospital, Monterrey, Mexico.. Annals of epidemiology. 24:771-775. 2014
- The effects of socioeconomic status, clinical factors, and genetic ancestry on pulmonary tuberculosis disease in northeastern Mexico. 2014
- Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients.. PLoS medicine. 9:-. 2012
- Upregulation of the phthiocerol dimycocerosate biosynthetic pathway by rifampin-resistant, rpoB mutant Mycobacterium tuberculosis.. Journal of bacteriology. 194:6441-6452. 2012
- Efficacy and safety of a 4-drug fixed-dose combination regimen compared with separate drugs for treatment of pulmonary tuberculosis: the Study C randomized controlled trial.. JAMA : the journal of the American Medical Association. 305:1415-1423. 2011
- Tuberculosis transmission risk and infection control in a hospital emergency department in Lima, Peru.. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 14:1120-1126. 2010
- Impact of bacterial genetics on the transmission of isoniazid-resistant Mycobacterium tuberculosis. 2006
- Treatment of multidrug-resistant tuberculosis in San Francisco: an outpatient-based approach.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 40:968-975. 2005
- Mycobacteria inhibit nitric oxide synthase recruitment to phagosomes during macrophage infection.. Infection and immunity. 72:2872-2878. 2004
- Effect of drug resistance on the generation of secondary cases of tuberculosis.. The Journal of infectious diseases. 188:1878-1884. 2003
Tuberculosis screening using ability to provide sputum in an endemic emergency department.. The European respiratory journal. -. 2015